COPD Trial, Recruiting NCT06335992 Sponsor: Uppsala University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06335992
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose lung function test (a breathing test called FEV1) shows a result between 30% and 85% of the expected normal value, measured after using a reliever inhaler
  • People who are already receiving the best available standard treatment for their lung condition, following recognised medical guidelines
  • People who do not have other significant health conditions that would limit their ability to exercise
  • People who have not smoked for at least one year
  • People who have not had a flare-up or worsening of their lung condition in the last 4 weeks
  • People with a body mass index (a measure of body weight relative to height) between 18 and 35

Who may not be able to join:

  • People who already regularly attend specially adapted or designed exercise sessions
  • People with an unstable heart or lung condition
  • People who currently smoke
  • People who, in the opinion of the trial doctor, have any other reason that would prevent them from safely taking part in an exercise training program (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Uppsala University
Registry
ClinicalTrials.gov
Start date
1 September 2022
Est. completion
1 December 2025

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Pulmonary Function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov